Wolin EM: Advances in the diagnosis and management of well-differentiated and intermediate-differentiated neuroendocrine tumors of the lung. Chest. 151:1141–1146. 2017.PubMed/NCBI View Article : Google Scholar

Oberndorfer S: Karzinoide tumoren des dünndarms. Frankfurter Zeischrift Pathol. 1:425–432. 1907.

Pelosi G, Bianchi F, Hofman P, Pattini L, Ströbel P, Calabrese F, Naheed S, Holden C, Cave J, Bohnenberger H, et al: Recent advances in the molecular landscape of lung neuroendocrine tumors. Expert Rev Mol Diagn. 19:281–297. 2019.PubMed/NCBI View Article : Google Scholar

Azzopardi JG: Oat-cell carcinoma of the bronchus. J Pathol Bacteriol. 78:513–519. 1959.PubMed/NCBI View Article : Google Scholar

Gould VE: Neuroendocrinomas and neuroendocrine carcinomas: APUD cell system neoplasms and their aberrant secretory activities. Pathol Annu. 12:33–62. 1977.PubMed/NCBI

Arrigoni MG, Woolner LB and Bernatz PE: Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg. 64:413–421. 1972.PubMed/NCBI

Eloesser L: Transthoracic bronchotomy for removal of benign tumors of the bronchi. Ann Surg. 112:1067–1070. 1940.PubMed/NCBI View Article : Google Scholar

Melosky B: Low grade neuroendocrine tumors of the lung. Front Oncol. 7(119)2017.PubMed/NCBI View Article : Google Scholar

Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A and Evans DB: One hundred years after ‘carcinoid’: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 26:3063–3072. 2008.PubMed/NCBI View Article : Google Scholar

Benzerdjeb N, Berna P and Sevestre H: GLUT1: A novel tool reflecting proliferative activity of lung neuroendocrine tumors? Pathol Int. 67:32–36. 2017.PubMed/NCBI View Article : Google Scholar

Peinado P, Arco CDD and Fernández-Aceñero MJ: Neuroendocrine tumors in rare locations: Description of 27 cases. Med Clin (Barc). 155:460–461. 2020.PubMed/NCBI View Article : Google Scholar : (In English, Spanish).

Warren WH, Gould VE, Faber LP, Kittle CF and Memoli VA: Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small cell carcinoma and intervening variants. J Thorac Cardiovasc Surg. 89:819–825. 1985.PubMed/NCBI

Lázaro S, Pérez-Crespo M, Lorz C, Bernardini A, Oteo M, Enguita AB, Romero E, Hernández P, Tomás L, Morcillo MÁ, et al: Differential development of large-cell neuroendocrine or small-cell lung carcinoma upon inactivation of 4 tumor suppressor genes. Proc Natl Acad Sci USA. 116:22300–22306. 2019.PubMed/NCBI View Article : Google Scholar

Hauso O, Gustafsson BI, Kidd M, Waldum HL, Drozdov I, Chan AK and Modlin IM: Neuroendocrine tumor epidemiology: Contrasting Norway and North America. Cancer. 113:2655–2664. 2008.PubMed/NCBI View Article : Google Scholar

Modlin IM, Lye KD and Kidd M: A 5 decade analysis of 13,715 carcinoid tumors. Cancer. 97:934–959. 2003.PubMed/NCBI View Article : Google Scholar

Broder MS, Cai B, Chang E and Neary MP: Incidence and prevalence of neuroendocrine tumors of the lung: Analysis of a US commercial insurance claims database. BMC Pulm Med. 18(135)2018.PubMed/NCBI View Article : Google Scholar

Rekhtman N: Neuroendocrine tumors of the lung: An update. Arch Pathol Lab Med. 134:1628–1638. 2010.PubMed/NCBI View Article : Google Scholar

Travis WD: Advances in neuroendocrine lung tumors. Ann Oncol. 21 (Suppl 7):vii65–vii71. 2010.PubMed/NCBI View Article : Google Scholar

Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, Oberg K, Pelosi G, Perren A, Rossi RE, et al: Pulmonary neuroendocrine (carcinoid) tumors: European neuroendocrine tumor society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol. 26:1604–1620. 2015.PubMed/NCBI View Article : Google Scholar

Travis WD, Brambilla E, Muller-Hermelink HK and Harris CC (eds): World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press, Lyon, pp179-184, 2004.

Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, de Krijger RR, Dietel M, El-Naggar AK, et al: A common classification framework for neuroendocrine neoplasms: An international agency for research on cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 31:1770–1786. 2018.PubMed/NCBI View Article : Google Scholar

Simbolo M, Mafficini A, Sikora KO, Fassan M, Barbi S, Corbo V, Mastracci L, Rusev B, Grillo F, Vicentini C, et al: Lung neuroendocrine tumours: Deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D. J Pathol. 241:488–500. 2017.PubMed/NCBI View Article : Google Scholar

Hendifar AE, Marchevsky AM and Tuli R: Neuroendocrine tumors of the lung: Current challenges and advances in the diagnosis and management of well-differentiated disease. J Thorac Oncol. 12:425–436. 2017.PubMed/NCBI View Article : Google Scholar

Pelosi G, Bianchi F, Dama E, Simbolo M, Mafficini A, Sonzogni A, Pilotto S, Harari S, Papotti M, Volante M, et al: Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: Innovative findings skipping the current pathogenesis paradigm. Virchows Arch. 472:567–577. 2018.PubMed/NCBI View Article : Google Scholar

Miller RR and Müller NL: Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors. Am J Surg Pathol. 19:653–658. 1995.PubMed/NCBI View Article : Google Scholar

Swarts DR, Ramaekers FC and Speel EJM: Molecular and cellular biology of neuroendocrine lung tumors: Evidence for separate biological entities. Biochim Biophys Acta. 1826:255–271. 2012.PubMed/NCBI View Article : Google Scholar

Phan AT, Öberg K, Choi J, Harrison LH Jr, Hassan MM, Strosberg JR, Krenning EP, Kocha W, Woltering EA and Maples WJ: North American Neuroendocrine Tumor Society (NANETS). NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: Well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus). Pancreas. 39:784–798. 2010.PubMed/NCBI View Article : Google Scholar

Gould VE, Memoli VA and Dardi LE: Multidirectional differentiation in human epithelial cancers. J Submicrosc Cytol. 13:97–115. 1981.

Savu C, Melinte A, Lukadi JL, Mirvald C, Savu C, Belu E, Diaconu C, Iliescu L, Balescu I, Stiru O, et al: Neuroendocrine syndrome in bronchial carcinoid tumors. Exp Ther Med. 20(200)2020.PubMed/NCBI View Article : Google Scholar

Detterbeck FC: Clinical presentation and evaluation of neuroendocrine tumors of the lung. Thorac Surg Clin. 24:267–276. 2014.PubMed/NCBI View Article : Google Scholar

Zainal A, Akinsola O and Rajamani K: Cushing syndrome secondary to primary neuroendocrine lung carcinoma. Case Rep Endocrinol. 2019(1989260)2019.PubMed/NCBI View Article : Google Scholar

Mitchell AN, Bakhos CT and Zimmerman EA: Anti-Ri-associated paraneoplastic brainstem cerebellar syndrome with coexisting limbic encephalitis in a patient with mixed large cell neuroendocrine lung carcinoma. J Clin Neurosci. 22:421–423. 2015.PubMed/NCBI View Article : Google Scholar

Sobin LH, Gospodarowicz MK and Wittekind C (eds): TNM classification of malignant tumours. 7th edition. John Wiley & Sons, West Sussex, 2011.

Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E, Flieder DB, et al: The 2015 World Health Organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 10:1243–1260. 2015.PubMed/NCBI View Article : Google Scholar

Lohinai Z, Megyesfalvi Z, Suda K, Harko T, Ren S, Moldvay J, Laszlo V, Rivard C, Dome B and Hirsch FR: Comparative expression analysis in small cell lung carcinoma reveals neuroendocrine pattern change in primary tumor versus lymph node metastases. Transl Lung Cancer Res. 8:938–950. 2019.PubMed/NCBI View Article : Google Scholar

Garg R, Bal A, Das A, Singh N and Singh H: Proliferation marker (Ki67) in sub-categorization of neuroendocrine tumours of the lung. Turk Patoloji Derg. 35:15–21. 2019.PubMed/NCBI View Article : Google Scholar

Halimi M, Ghorbani T, Tabrizi AD, Khamnian Z and Pourasghary S: Association of Ki67 antigen with mitotic count, tumor size, and Necrosis in Neuroendocrine Tumors of Lung. Cres J Med Biol Sci. 7:398–403. 2020.

Fabbri A, Cossa M, Sonzogni A, Papotti M, Righi L, Gatti G, Maisonneuve P, Valeri B, Pastorino U and Pelosi G: Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied. Virchows Arch. 470:153–164. 2017.PubMed/NCBI View Article : Google Scholar

Zhao LH, Chen C, Mao CY, Xiao H, Fu P, Xiao HL and Wang G: Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors. Pathol Res Pract. 215(152448)2019.PubMed/NCBI View Article : Google Scholar

Folpe AL, Gown AM, Lamps LW, Garcia R, Dail DH, Zarbo RJ and Schmidt RA: Thyroid transcription factor-1: Immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol. 12:5–8. 1999.PubMed/NCBI

Del Gobbo A, Fusco N, Barella M, Ercoli G, Sciarra A, Palleschi A, Pagni F, Marchiò C, Papotti M and Ferrero S: CXCL12 expression is a bona fide predictor of recurrence in lung neuroendocrine tumours; a multicentric study with emphasis on atypical carcinoids-a short report. Cell Oncol (Dordr). 41:687–691. 2018.PubMed/NCBI View Article : Google Scholar

Kim M, Chung YS, Kim KA and Shim HS: Genomic profiling and clinicopathological characteristics of neuroendocrine tumors of the lung in East Asian patients. In Vivo. 34:3375–3385. 2020.PubMed/NCBI View Article : Google Scholar

Gazzeri S, Gouyer V, Vour'ch C, Brambilla C and Brambilla E: Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Oncogene. 16:497–504. 1998.PubMed/NCBI View Article : Google Scholar

Malczewska A, Oberg K, Bodei L, Aslanian H, Lewczuk A, Filosso PL, Wójcik-Giertuga M, Rydel M, Zielińska-Leś I, Walter A, et al: NETest liquid biopsy is diagnostic of lung neuroendocrine tumors and identifies progressive disease. Neuroendocrinology. 108:219–231. 2019.PubMed/NCBI View Article : Google Scholar

Lázaro S, Pérez-Crespo M, Enguita AB, Hernández P, Martínez-Palacio J, Oteo M, Sage J, Paramio JM and Santos M: Ablating all three retinoblastoma family members in mouse lung leads to neuroendocrine tumor formation. Oncotarget. 8:4373–4386. 2017.PubMed/NCBI View Article : Google Scholar

Brominska B, Gabryel P, Jarmołowska-Jurczyszyn D, Janicka-Jedyńska M, Trojanowski M, Sawicka-Gutaj N, Czepczyński R, Gut P, Bromiński G, Dyszkiewicz W, et al: Clinical significance of nestin and its association with survival in neuroendocrine lung tumours. Pol J Pathol. 68:291–296. 2017.PubMed/NCBI View Article : Google Scholar

Shimizu K, Goto Y, Kawabata-Iwakawa R, Ohtaki Y, Nakazawa S, Yokobori T, Obayashi K, Kawatani N, Yajima T, Kaira K, et al: Stathmin-1 is a useful diagnostic marker for high-grade lung neuroendocrine tumors. Ann Thorac Surg. 108:235–243. 2019.PubMed/NCBI View Article : Google Scholar

George J, Walter V, Peifer M, Alexandrov LB, Seidel D, Leenders F, Maas L, Müller C, Dahmen I, Delhomme TM, et al: Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. Nat Commun. 9(1048)2018.PubMed/NCBI View Article : Google Scholar

Tsuruoka K, Horinouchi H, Goto Y, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Keisuke A, Nakagawa K, Sakurai H, et al: PD-L1 expression in neuroendocrine tumors of the lung. Lung Cancer. 108:115–120. 2017.PubMed/NCBI View Article : Google Scholar

Kim HS, Lee JH, Nam SJ, Ock CY, Moon JW, Yoo CW, Lee GK and Han JY: Association of PD-L1 expression with tumor-infiltrating immune cells and mutation burden in high-grade neuroendocrine carcinoma of the lung. J Thorac Oncol. 13:636–648. 2018.PubMed/NCBI View Article : Google Scholar

Inamura K, Yokouchi Y, Kobayashi M, Ninomiya H, Sakakibara R, Nishio M, Okumura S and Ishikawa Y: Relationship of tumor PD-L1 (CD274) expression with lower mortality in lung high-grade neuroendocrine tumor. Cancer Med. 6:2347–2356. 2017.PubMed/NCBI View Article : Google Scholar

Ohtaki Y, Kaira K, Atsumi J, Nagashima T, Kawashima O, Ibe T, Kamiyoshihara M, Onozato R, Fujita A, Yazawa T, et al: Prognostic significance of PD-L1 expression and tumor infiltrating lymphocytes in large cell neuroendocrine carcinoma of lung. Am J Transl Res. 10:3243–3253. 2018.PubMed/NCBI

Zhang W, Girard L, Zhang YA, Haruki T, Papari-Zareei M, Stastny V, Ghayee HK, Pacak K, Oliver TG, Minna JD and Gazdar AF: Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes. Transl Lung Cancer Res. 7:32–49. 2018.PubMed/NCBI View Article : Google Scholar

Savu C, Grigorie V, Melinte A, Diaconu C, Iliescu L, Dimitriu M, Balescu I and Bacalbasa N: Giant intrathoracic schwannoma: A case report. In Vivo. 34:3527–3532. 2020.PubMed/NCBI View Article : Google Scholar

Galvano A, Peri M, Guarini AA, Castiglia M, Grassadonia A, De Tursi M, Irtelli L, Rizzo S, Bertani A, Gristina V, et al: Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: Prognostic and predictive significance of NLR, LDH, ALI, and LIPI score. Ther Adv Med Oncol. 12(1758835920942378)2020.PubMed/NCBI View Article : Google Scholar

Sakakibara R, Kobayashi M, Takahashi N, Inamura K, Ninomiya H, Wakejima R, Kitazono S, Yanagitani N, Horiike A, Ichinose J, et al: Insulinoma-associated protein 1 (INSM1) is a better marker for the diagnosis and prognosis estimation of small cell lung carcinoma than neuroendocrine phenotype markers such as chromogranin A, synaptophysin, and CD56. Am J Surg Pathol. 44:757–764. 2020.PubMed/NCBI View Article : Google Scholar

Russo L, Grilli B, Minopoli A, Capozzi M, Tafuto S, Correra M, Trillò G, Isgrò MA and Cavalcanti E: A potential prognostic marker in primitive lung neuroendocrine tumor: A case report. Int J Biol Markers. 35:102–106. 2020.PubMed/NCBI View Article : Google Scholar

Leal JL, Peters G, Szaumkessel M, Leong T, Asadi K, Rivalland G, Do H, Senko C, Mitcell PL, Quing CZ, et al: NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer. Lung Cancer. 146:154–159. 2020.PubMed/NCBI View Article : Google Scholar

Pirvu A, Angelescu D and Savu C: Localized fibrous tumor of the pleura un unusual cause of severe hypoglycaemia. Case report. Rev Med Chir Soc Med Nat Iasi. 120:628–630. 2016.PubMed/NCBI

Savu C, Melinte A, Posea R, Galie N, Balescu I, Diaconu C, Cretoiu D, Dima S, Filipescu A, Balalau C and Bacalbasa N: Pleural solitary fibrous tumors-a retrospective study on 45 patients. Medicina (Kaunas). 56(185)2020.PubMed/NCBI View Article : Google Scholar

Savu C, Melinte A, Balescu I and Bacalbasa N: Azygos vein aneurysm mimicking a mediastinal mass. In Vivo. 34:2135–2140. 2020.PubMed/NCBI View Article : Google Scholar

Sparaneo A, Fabrizio FP, la Torre A, Graziano P, Di Maio M, Fontana A, Bisceglia M, Rossi A, Pizzolitto S, De Maglio G, et al: Effects of KEAP1 silencing on the regulation of NRF2 activity in neuroendocrine lung tumors. Int J Mol Sci. 20(2531)2019.PubMed/NCBI View Article : Google Scholar

Brcic L, Kuchler C, Eidenhammer S, Pabst D, Quehenberger F, Gazdar AF and Popper H: Comparison of four DLL3 antibodies performance in high grade neuroendocrine lung tumor samples and cell cultures. Diagn Pathol. 14(47)2019.PubMed/NCBI View Article : Google Scholar

Yoxtheimer LM, Heymann JJ, Cohen C, Rao RA, Goyal A and Siddiqui MT: Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas. Diagn Cytopathol. 46:1010–1014. 2018.PubMed/NCBI View Article : Google Scholar

Detassis S, Del Vescovo V, Grasso M, Masella S, Cantaloni C, Cima L, Cavazza A, Graziano P, Rossi G, Barbareschi M, et al: miR375-3p distinguishes low-grade neuroendocrine from non-neuroendocrine lung tumors in FFPE samples. Front Mol Biosci. 7(86)2020.PubMed/NCBI View Article : Google Scholar

Jeung MY, Gasser B, Gangi A, Charneau D, Ducroq X, Kessler R, Quoix E and Roy C: Bronchial carcinoid tumors of the thorax: Spectrum of radiologic findings. Radiographics. 22:351–365. 2002.PubMed/NCBI View Article : Google Scholar

Boutsikou E, Porpodis K, Chatzipavlidou V, Hardavella G, Gerasimou G, Domvri K, Papadopoulos N, Avramidou V, Spyratos D, Kontakiotis T and Zarogoulidis K: Predictive value of 99MTC-hynic-toc scintigraphy in lung neuroendocrine tumor diagnosis. Technol Cancer Res Treat. 18(1533033819842586)2019.PubMed/NCBI View Article : Google Scholar

Tripathy S, Ballal S, Yadav MP, Joshi P, Bal C and Damle NA: Coexistence of multiple metastatic lesions showing various grades of differentiation in a single patient with neuroendocrine tumor of lung as primary: A combined modality approach of ⁶⁸Ga-DOTANOC positron emission tomography/computed tomography and ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography imaging. Indian J Nucl Med. 34:260–262. 2019.PubMed/NCBI View Article : Google Scholar

Singh S, Bergsland EK, Card CM, Hope TA, Kunz PL, Laidley DT, Lawrence B, Leyden S, Metz DC, Michael M, et al: Commonwealth neuroendocrine tumour research collaboration and the North American neuroendocrine tumor society guidelines for the diagnosis and management of patients with lung neuroendocrine tumors: An international collaborative endorsement and update of the 2015 European neuroendocrine tumor society expert consensus guidelines. J Thorac Oncol. 15:1577–1598. 2020.PubMed/NCBI View Article : Google Scholar

Filosso PL, Guerrera F, Evangelista A, Galassi C, Welter S, Rendina EA, Travis W, Lim E, Sarkaria I and Thomas PA: ESTS Lung Neuroendocrine Working Group Contributors. Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: Results from the European society for thoracic surgeons lung neuroendocrine tumours retrospective database. Eur J Cardiothorac Surg. 52:339–345. 2017.PubMed/NCBI View Article : Google Scholar

Mauclet C, Duplaquet F, Pirard L, Rondelet B, Dupont M, Pop-Stanciu C, Vander Borght T, Remmelink M, D'Haene N, Lambin S, et al: Complete tumor response of a locally advanced lung large-cell neuroendocrine carcinoma after palliative thoracic radiotherapy and immunotherapy with nivolumab. Lung Cancer. 128:53–56. 2019.PubMed/NCBI View Article : Google Scholar

Balasubramaniam S, Redon CE, Peer CJ, Bryla C, Lee MJ, Trepel JB, Tomita Y, Rajan A, Giaccone G, Bonner WM, et al: Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung. Anticancer Drugs. 29:457–465. 2018.PubMed/NCBI View Article : Google Scholar

Peri M and Fazio N: Clinical evaluation of everolimus in the treatment of neuroendocrine tumors of the lung: Patient selection and special considerations. A systematic and critical review of the literature. Lung Cancer (Auckl). 11:41–52. 2020.PubMed/NCBI View Article : Google Scholar